Table 1.
Gender | Age [years] | Topographic location | Histopathology of primary lesion | Histopathology of secondary lesion | IP of primary lesion [%] | IP of secondary lesion [%] | Time span to confirmed recurrence [months] | Postoperative period free from recurrences [years] |
---|---|---|---|---|---|---|---|---|
M | 78 | Medial canthus RE | BCC with trichilemmal differentiation | 8 | 26 | 16 | 2 | |
F | 70 | Le RE | 8 | 11 | 8 | 1 | ||
M | 71 | Medial canthus LE | 5 | 15 | 13 | 3 | ||
F | 74 | Le LE | 6 | 13 | 9 | 2 | ||
M | 73 | Medial canthus LE | 10 | 29 | 18 | 3 | ||
F | 61 | Le LE | BCC – nodular type | 7 | 14 | 7 | 3 | |
F | 54 | Lateral canthus RE | 20 | 13 | 8 | 1 | ||
F | 65 | Medial canthus RE | 10 | 18 | 18 | 1 | ||
F | 60 | Medial canthus LE | 12 | 21 | 16 | 2 | ||
M | 70 | Medial canthus RE | 9 | 15 | 14 | 3 | ||
M | 69 | Medial canthus LE | 14 | 28 | 20 | 3 | ||
F | 79 | Medial canthus LE | BCC – nodular-infiltrating type | 18 | 25 | 30 | 2 | |
F | 74 | Medial canthus RE | 15 | 27 | 15 | 3 | ||
F | 73 | Lateral canthus LE | BCC – infiltrating type | 1 | 12 | 23 | 9 | |
M | 70 | Le RE | 5 | 20 | 18 | 5 | ||
F | 73 | Medial canthus LE | BCC – superficial type | BCC – nodular type | 6 | 39 | 21 | 3 |
F | 68 | Le LE | 10 | 48 | 15 | 3 | ||
M | 72 | Le LE | BCC – nodular type | BCC – infiltrating type | 7 | 17 | 5.5 | 4 |
M | 75 | Le RE | 10 | 24 | 7 | 4 |
IP – proliferation index, M – male, F – female, Le – lower eyelid, RE – right eye, LE – left eye.